Medicines are shifting from one size fits all to targeted therapeutics. Learn more about accelerating development of targeted therapies and companion diagnostics, optimizing clinical trials, and simplifying commercial supply.
Download our new thought leadership e-book to learn about how we are accelerating drug development and delivery.
Madison Pagel was diagnosed with aggressive pediatric brain cancer at only 4-months old. Genetic analysis tools helped doctors design a life-saving clinical trial for children with end-stage brain cancer. Maddie’s story is why we all put in long hours.
|Video||Cancer Patient Finds Hope and Remission in CAR T-Cell Therapy||Targeted Therapeutics|
|Video||Advancing Precision Medicine, Better Pediatric Care, and the Role of Next-Generation Sequencing||Targeted Therapeutics, Molecular Diagnostics|
|Article||Cancer: Still a Multidimensional Challenge||Targeted Therapeutics, Molecular Diagnostics|
|e-book||From Molecule to Medicine||Targeted Therapeutics|
|Article||Next-Generation Sequencing: Marking the Lead from Concept to Clinic||Translational Research, Targeted Therapeutics|
|Blog||A Huge Step Forward for Immunotherapy: First Ever FDA Approved CAR-T Cell Therapy||Targeted Therapeutics|
|Interview||Addressing the Challenges of Commercial-Scale Manufacture of Viral Vectors for CAR-T Therapies||Translational Research, Targeted Therapeutics|
|Case study||Global Ultra-Cold Clinical Trial Logistics||Targeted Therapeutics|